Trials / Sponsors / Guangdong Ruishun Biotech Co., Ltd
Guangdong Ruishun Biotech Co., Ltd
Industry · 5 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies B-cell Non-Hodgkin's Lymphoma, Acute Lymphoblastic Leukemia | Phase 1 | 2025-04-01 |
| Not Yet Recruiting | A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL B-cell Non-Hodgkin's Lymphoma | Phase 1 | 2024-05-20 |
| Not Yet Recruiting | A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus | Phase 1 | 2024-05-15 |
| Recruiting | RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2023-05-04 |
| Unknown | Phase I Clinical Trial of RC1012 Injection in Patients With r/r AML Acute Myeloid Leukemia | Phase 1 | 2021-01-14 |